Malin Life Sciences Holdings Ltd

Malin Life Sciences Holdings Ltd appears in our data through filings on Poseida Therapeutics, Inc. shares, published by SEC (Form 4). In total, 7 filings cover trades dated from 16 November 2021 to 8 January 2025.

Every open-market trade on record is a purchase: 6 purchases worth €7.8M, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

In size, the median ticket on the buying side is €123k. On 6 out of 6 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.

The latest filing, published on 10 January 2025, reports a transaction in Poseida Therapeutics, Inc. The latest purchase dates back some time: it was published 1,530 days ago, on 10 August 2022. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.